Literature DB >> 22013141

Hemiplegic migraine, seizures, progressive spastic paraparesis, mood disorder, and coma in siblings with low systemic serotonin.

Gabriella A Horvath1, Kathryn Selby, Ken Poskitt, Keith Hyland, Paula J Waters, Marion Coulter-Mackie, Sylvia G Stockler-Ipsiroglu.   

Abstract

BACKGROUND: Serotonin has an important role in vascular resistance and blood pressure control, and a functional serotonin transporter polymorphism has been associated with migraine. Disturbances in serotonin metabolism have been associated with autism, depression, and myoclonus related conditions, but serotonin has far more functions in the body. Familial hemiplegic migraine is a rare autosomal dominant subtype of migraine with aura in which attacks are associated with hemiparesis. CASES: We present two siblings with hemiplegic migraine, depression, progressive spastic paraparesis, myelopathy, and spinal cord atrophy. One of the sisters presented with prolonged coma after a migraine episode. Both sisters were found to have low cerebrospinal fluid serotonin metabolite (5-hydroxyindoleacetic acid), low platelet serotonin levels, and diminished serotonin transport capacity. Their clinical symptoms improved on 5-hydroxytryptophan replacement therapy. Mutational analysis of the CACNA1A and ATP1A2 genes was negative.
CONCLUSION: This is the first time that systemic serotonin deficiency has been described in familial hemiplegic migraine. We hypothesize that the deficiency of serotonin transport may be part of a complex cellular membrane trafficking dysfunction involving not only the serotonin transporter but also other transporters and ion channels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013141     DOI: 10.1177/0333102411420584

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by ALDH7A1 genetic defect.

Authors:  Saadet Mercimek-Mahmutoglu; Dawn Corderio; Laura Nagy; Carly Mutch; Melissa Carter; Eduard Struys; Lianna Kyriakopoulou
Journal:  Mol Genet Metab Rep       Date:  2014-04-01

Review 2.  Genetic and biochemical changes of the serotonergic system in migraine pathobiology.

Authors:  Claudia Francesca Gasparini; Robert Anthony Smith; Lyn Robyn Griffiths
Journal:  J Headache Pain       Date:  2017-02-13       Impact factor: 7.277

Review 3.  The exploration of mechanisms of comorbidity between migraine and depression.

Authors:  Qing Zhang; Anwen Shao; Zhengyan Jiang; Huitzong Tsai; Weibo Liu
Journal:  J Cell Mol Med       Date:  2019-05-20       Impact factor: 5.310

4.  Decreased content of ascorbic acid (vitamin C) in the brain of knockout mouse models of Na+,K+-ATPase-related neurologic disorders.

Authors:  Keiko Ikeda; Adriana A Tienda; Fiona E Harrison; Kiyoshi Kawakami
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

Review 5.  Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis.

Authors:  Heba M Kalbouneh; Ahmad A Toubasi; Farah H Albustanji; Yazan Y Obaid; Layla M Al-Harasis
Journal:  J Am Heart Assoc       Date:  2022-06-22       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.